newsfilter
← Latest News
PR Newswire·

BioLineRx to Report Third Quarter 2024 Results on November 25, 2024

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare...